Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Guangzhou Yue Min Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$71M
Portfolio companies 3
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Key employees Soon

Areas of investment

  • Health Care
  • Health Diagnostics
  • Medical Device
  • Information Services
  • Information Technology
Summary

The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2019. The common things for fund are deals in the range of more than 100 millions dollars.

The standard case for the fund is to invest in rounds with 7 partakers. Despite the Guangzhou Yue Min Investment, startups are often financed by OrbiMed. The meaningful sponsors for the fund in investment in the same round are South China Venture Capital, Pan-Lin Asset Management, OrbiMed.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Alternative Medicine, Health Care. Among the various public portfolio startups of the fund, we may underline Apollomics

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerasia Ventures Central Region, Singapore, Singapore
Avetta California, Irvine, United States
Calega -
Chengshi Dingxin -
Dickey Revocable Living Trust -
Funcity Capital China, Hangzhou, Zhejiang
Gooray Tax Chengguan District, China, Lhasa
Hollencrest Capital Management California, Newport Beach, United States
Lucros Investment -
Shanghai Rizhang Investment Management China, Shanghai
Sprout Fund LP Alberta, Canada, Edmonton
St. Luke's University Health Network Bethlehem, Pennsylvania, United States
Stonehenge Growth Equity Florida, Tampa, United States
Sulphur Creek Ventures California, St. Helena, United States
Ulupono Initiative Hawaii, Honolulu, United States
VGangels -
Zhengming Modern Logistics China, Qingpu, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Centrymed

Health Care
Health Diagnostics
Medical Device
09 Feb 2022 Hangzhou, Zhejiang, China

Centrymed

Health Care
Health Diagnostics
Medical Device
01 Jan 2022 Hangzhou, Zhejiang, China

Iluvatar CoreX

Artificial Intelligence
Cloud Computing
Information Services
Information Technology
Software
$185M01 Mar 2021 Xuanwu District, Jiangsu, China

Apollomics

Biotechnology
Health Care
Pharmaceutical
$100M08 Jan 2019 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Guangzhou Yue Min Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 71M
Peak activity year 2022
Lead investments 0
Follow on index 0.25
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Centrymed

Health Care
Health Diagnostics
Medical Device
09 Feb 2022 Hangzhou, Zhejiang, China

Centrymed

Health Care
Health Diagnostics
Medical Device
01 Jan 2022 Hangzhou, Zhejiang, China

Iluvatar CoreX

Artificial Intelligence
Cloud Computing
Information Services
Information Technology
Software
$185M01 Mar 2021 Xuanwu District, Jiangsu, China

Apollomics

Biotechnology
Health Care
Pharmaceutical
$100M08 Jan 2019 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: